Eric L. Reyner
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
Papers in
- Oncology 12
- Drug Transport and Resistance Mechanisms 8
- HER2/EGFR in Cancer Research 3
- Co-authors
- Barbra H. Stewart (7 shared papers)O. Helen Chan (3 shared papers)Caroline A. Lee (3 shared papers)Lloyd R. Whitfield (2 shared papers)Edward J. Randinitis (2 shared papers)Rebecca A. Boyd (2 shared papers)William L. Elliott (2 shared papers)Joseph A. Loo (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)Drug Metabolism and Disposition (3 papers)Pharmaceutical Research (2 papers)The Journal of Clinical Pharmacology (2 papers)Genomics (2 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Eric L. Reyner
23 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 100
- Pharmacology 177
- Oncology 495
- Pharmaceutical Science 83
- Pediatrics, Perinatology and Child Health 177
- Organic Chemistry 229
Countries citing papers authored by Eric L. Reyner
This map shows the geographic impact of Eric L. Reyner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric L. Reyner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric L. Reyner more than expected).
Fields of papers citing papers by Eric L. Reyner
This network shows the impact of papers produced by Eric L. Reyner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric L. Reyner. The network helps show where Eric L. Reyner may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric L. Reyner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 217 | |
| 2 | 2011 | 186 | |
| 3 | 1995 | 149 | |
| 4 | 2000 | 139 | |
| 5 | 1997 | 81 | |
| 6 | 2010 | 58 | |
| 7 | 2011 | 57 | |
| 8 | 2010 | 39 | |
| 9 | 2013 | 32 | |
| 10 | Localization of DNA sequences to a region within Xp11.21 between incontinentia pigmenti (IP1) X-chromosomal translocation breakpoints. | 1991 | 29 |
| 11 | 1995 | 25 | |
| 12 | 2000 | 25 | |
| 13 | 2002 | 18 | |
| 14 | 1992 | 16 | |
| 15 | 2019 | 15 | |
| 16 | 2000 | 12 | |
| 17 | 1996 | 9 | |
| 18 | 1992 | 8 | |
| 19 | 1996 | 5 | |
| 20 | 2019 | 4 |
About Eric L. Reyner
Eric L. Reyner is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pediatrics, Perinatology and Child Health and Infectious Diseases, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), HER2/EGFR in Cancer Research (3 papers), Nitric Oxide and Endothelin Effects (3 papers), HIV/AIDS drug development and treatment (3 papers), Genetic and rare skin diseases. (3 papers) and Quinazolinone synthesis and applications (2 papers). The work is most often cited by research in Pharmacology (177 citations), Oncology (495 citations), Pharmaceutical Science (83 citations), Pediatrics, Perinatology and Child Health (177 citations) and Organic Chemistry (229 citations). Eric L. Reyner has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Barbra H. Stewart, O. Helen Chan, Caroline A. Lee, Lloyd R. Whitfield, Edward J. Randinitis, Rebecca A. Boyd, William L. Elliott, Joseph A. Loo, Kenneth D. Greis and H. D. Hollis Showalter. Their work appears in journals such as Journal of Medicinal Chemistry, Drug Metabolism and Disposition, Pharmaceutical Research, The Journal of Clinical Pharmacology and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.